Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and ...
Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022
Stay updated with breaking news from Increase Compared. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022
Financial Highlights: 22.2% Increase in Q4 2023 Revenue Compared to Q4 2022; 2.6% Increase Compared to Q3 2023; Full Year 2023 Revenue Declines 9.2% Compared to Prior Year560 Basis Point Increase in...
~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October...
Reports a Strong Second Quarter with Net Investment Income of $0.38 Per Share and a 3.0% Increase in Net Asset Value to $35.68 Per Share Compared to the Prior Quarter ...
/PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce that its Board of Directors declared regular monthly cash...